NMPA Approval

Mixed Protanine Zinc Recombinant Human Insulin Lispro Injection(25R)

Approval Number

国药准字S20140005

Company甘李药业股份有限公司

Registration Date

February 1, 2024

Drug Information

Generic Name

精蛋白锌重组赖脯胰岛素混合注射液(25R)

Brand Name

速秀霖25R

Dosage Form

注射剂

Strength

3ml:300单位(笔芯)

Drug Type

生物制品

Registration Date

February 1, 2024

Company Information

Applicant Company

Company Name甘李药业股份有限公司

Company Address

北京市通州区漷县镇南凤西一路8号

Manufacturing Company

Company Name甘李药业股份有限公司

Company Address

北京市通州区漷县镇南凤西一路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

精蛋白锌重组赖脯胰岛素混合注射液(25R) - NMPA 批准文号 | MedPath